DrugPatentWatch Database Preview
Bionpharma Inc Company Profile
What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?
BIONPHARMA INC has twenty-four approved drugs.
There are five US patents protecting BIONPHARMA INC drugs.
There are nineteen patent family members on BIONPHARMA INC drugs in seventeen countries and twenty-four supplementary protection certificates in eleven countries.
Summary for Bionpharma Inc
International Patents: | 19 |
US Patents: | 5 |
Tradenames: | 24 |
Ingredients: | 21 |
NDAs: | 24 |
Drug Master File Entries: | 2 |
Patent Litigation for Bionpharma Inc: | See patent lawsuits for Bionpharma Inc |
Drugs and US Patents for Bionpharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bionpharma Inc | CLOBAZAM | clobazam | TABLET;ORAL | 208825-002 | Oct 22, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Bionpharma Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 209753-003 | Mar 2, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Bionpharma Inc | CLOBAZAM | clobazam | SUSPENSION;ORAL | 208819-001 | Oct 22, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Bionpharma Inc | DUTASTERIDE | dutasteride | CAPSULE;ORAL | 200899-001 | Nov 20, 2015 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Bionpharma Inc | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 202539-002 | Mar 27, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Bionpharma Inc | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | OTC | Yes | Yes | 10,028,925 | ➤ Sign Up | Y | ➤ Sign Up | |||
Bionpharma Inc | CLOBAZAM | clobazam | TABLET;ORAL | 208825-001 | Oct 22, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Bionpharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bionpharma Inc | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Bionpharma Inc Drugs
Country | Document Number | Estimated Expiration |
---|---|---|
Slovenia | 1863458 | ➤ Sign Up |
European Patent Office | 1207872 | ➤ Sign Up |
Poland | 1863458 | ➤ Sign Up |
Poland | 362850 | ➤ Sign Up |
China | 101166520 | ➤ Sign Up |
Cyprus | 1118321 | ➤ Sign Up |
Japan | 2003508434 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Inc Drugs
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
C/GB98/013 | United Kingdom | ➤ Sign Up | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
00002 | Netherlands | ➤ Sign Up | PRODUCT NAME: DOFETILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/99/121/001 - EU/1/99/121/015 19991129 |
/2003 | Austria | ➤ Sign Up | PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719 |
00C/005 | Belgium | ➤ Sign Up | PRODUCT NAME: DOFETILIDE; REGISTRATION NO/DATE: EU/1/99/121/001 19991129 |
C0027 | France | ➤ Sign Up | PRODUCT NAME: BEXAROTENE; REGISTRATION NO/DATE: EU/1/01/178/001 20010329 |
00054 | Netherlands | ➤ Sign Up | PRODUCT NAME: BEXAROTENE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF IN DE VORM VAN EEN ESTER MET EEN HYDROXYVER- BINDING MET DE FORMULE R9OH, WAARIN R9 EEN; NAT. REGISTRATION NO/DATE: EU/1/01/178/001 20010329; FIRST REGISTRATION: EU/1/01/178/001 20010329 |
2012 00035 | Denmark | ➤ Sign Up | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.